tofacitinib,ustekinumab
pfizer,Janssen
['advance', 'ibd']
advancements in #ibd treatment have led to more patients in remission &amp; less requiring surgery. now, experts like , co-director of our ibd center, are focusing on early intervention &amp; tailoring medication. read about new research: #acg2022
Ranked #2 Best Medical School and #3 Best Hospital in the nation by U.S. News & World Report.